Mechanisms of in vivo binding site selection of the hematopoietic master transcription factor PU.1
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The transcription factor PU.1 is crucial for the development of many hematopoietic lineages and its binding patterns significantly change during differentiation processes. However, the 'rules' for binding or not-binding of potential binding sites are only partially understood. To unveil basic characteristics of PU.1 binding site selection in different cell types, we studied the binding properties of PU.1 during human macrophage differentiation. Using in vivo and in vitro binding assays, as well as computational prediction, we show that PU.1 selects its binding sites primarily based on sequence affinity, which results in the frequent autonomous binding of high affinity sites in DNase I inaccessible regions (25-45% of all occupied sites). Increasing PU.1 concentrations and the availability of cooperative transcription factor interactions during lineage differentiation both decrease affinity thresholds for in vivo binding and fine-tune cell type-specific PU.1 binding, which seems to be largely independent of DNA methylation. Occupied sites were predominantly detected in active chromatin domains, which are characterized by higher densities of PU.1 recognition sites and neighboring motifs for cooperative transcription factors. Our study supports a model of PU.1 binding control that involves motif-binding affinity, PU.1 concentration, cooperativeness with neighboring transcription factor sites and chromatin domain accessibility, which likely applies to all PU.1 expressing cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4. Motif scores correlate with in vitro binding affinity. (A) The ChIP-seq–derived PU.1 consensus PWM (sequence logo is shown on top) comprises ∼3300 different 12mers. Twenty-five representative 12mers overlapping the PWM are shown below the logo next to their motif log-odds scores. (B) Scatter plot showing scores of motifs relative to the frequency of in vivo binding events across the repeat-masked genome (only motifs with >100 occurrences across the masked genome are included). (C) Scatter plot showing the correlation between microscale thermophoresis-derived dissociation constants (KD-values) for the interaction between recombinant full-length PU.1 and double-stranded oligonucleotides [including the ones listed in (A)] with corresponding motif log-odds scores. Only KD-values <1500 mM were plotted. Oligos with larger KD-values (between 1500 and 4500 mM, 12 in total) had low-log-odds scores (between 6.7 and 7.6). A complete list of KD- and log-odds score values is given in Supplementary Table S1.](https://figures.cochat.ai/paper-figures/864bdea913fb4c669e4915177e40e128/mechanisms-of-in-vivo-binding-site-selection-of-the-hematopoietic-master-figure-4.jpg)


![Figure 7. Differential distribution of bound and non-bound PU.1 consensus sites on the level of chromatin domains. (A) Genome browser tracks of a representative 750-kb genomic interval on chromosome 11 for H3K4me1 (osteoblasts, liver, T cells and MO) and PU.1 (MO). CTCF-flanked regions are indicated by colored boxes [coloring indicates the H3K4me1 tag density (TC/bp; normalized tag count per base pair)]. Positions of bound (blue) and non-bound (brown) consensus motifs are also provided. Motif scores in the respective tracks are indicated by color ranges (light to dark coloring corresponds to low to high scores). (B) Bar chart of bound (red) and non-bound (gray) motif frequencies across domain activity bins. (C) Tag count per base pair ratios for MO versus osteoblasts (OB) are plotted against average tag counts for CTCF-flanked domains (MvA plot). The correlation coefficient for the direct comparison of log-transformed tag counts (TC) per base pair are given above the diagram. (D) Distribution of normalized PU.1 ChIP-seq tag counts around motifs contingent on motif score classes in domains showing cell type-specific activity. The horizontal bar indicates the median of each distribution. The dotted line indicates the tag threshold for peaks considered bound. (E) Combined bean and box plot showing the distribution of motif log-odds scores for the all PU.1 motifs (total) or MO-bound PU.1 motifs within cell type-specific domains. Solid bars of boxes display the interquartile ranges (25–75%) with an intersection as the median; whiskers represent min/max. Coloring indicates the type of domain. Significantly different motif score distributions in pairwise comparisons are indicated (***P < 0.001, Mann–Whitney U test, two-sided). (F) Bar chart of non-bound and bound motif frequencies in OB- or MO-specific domains. The additional boxed chart shows frequencies of bound motifs overlapping DNase I accessible sites in MO.](https://figures.cochat.ai/paper-figures/cc67de46e2724239b76b2bed25801f0f/mechanisms-of-in-vivo-binding-site-selection-of-the-hematopoietic-master-figure-7.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Instead, activation of common housekeeping genes is associated with an enrichment of SPI1 occupancy at promoters without requiring lineage-specific coactivators but with a higher affinity of binding to chromatin compared to enhancers (6,7,68).”
From HDAC1 and PRC2 mediate combinatorial control in SPI1/PU.1-dependent gene repression in murine erythroleukaemia (2022) · cites this paper as [68]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In myeloid and B-lymphoid cells, SPI1 activates lineage-specific genes due to lineage-specific coactivators at enhancers (6,7,68).”
From HDAC1 and PRC2 mediate combinatorial control in SPI1/PU.1-dependent gene repression in murine erythroleukaemia (2022) · cites this paper as [68]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“typically (A/G)AGGAAGTG motifs [e.g., (10, 11)]”
From Mechanisms of Action of Hematopoietic Transcription Factor PU.1 in Initiation of T-Cell Development (2019) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
Self-citationHigh-Resolution Profiling of Histone Methylations in the Human Genome
Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., & Zhao, K. (2007) · Cell · doi:10.1016/j.cell.2007.05.009 · Cited by 6,845 · cited 1×
“1 elements were enriched in gene deserts or chromatin domains (defined as being flanked by the boundary transcription factor CTCF) that lack domain-wide monomethylation of histone H3 at lysine 4, a modification that correlates with transcriptional activity (41).”
The accessible chromatin landscape of the human genome
Thurman, R. E., Rynes, E., Humbert, R., Vierstra, J., Maurano, M. T., Haugen, E., Sheffield, N. C., Stergachis, A. B., Wang, H., Vernot, B., et al. (2012) · Nature · doi:10.1038/nature11232 · Cited by 2,679 · cited 6×
“By comparing DNase I cleavage patterns [publicly available for MO and HPC, (31)] with PU.1 occupancy, we noticed a substantial proportion of PU.1-binding sites that showed no overlap with DNase I cleaved regions.”
InfluentialCarroll, J. S., Liu, X. S., Brodsky, A. S., Li, W., Meyer, C. A., Szary, A. J., Eeckhoute, J., Shao, W., Hestermann, E. V., Geistlinger, T. R., et al. (2005) · Cell · doi:10.1016/j.cell.2005.05.008 · Cited by 1,384
DNA-binding factors shape the mouse methylome at distal regulatory regions
Stadler, M. B., Murr, R., Burger, L., Ivanek, R., Lienert, F., Schöler, A., Nimwegen, E. V., Wirbelauer, C., Oakeley, E. J., Gaidatzis, D., et al. (2011) · Nature · doi:10.1038/nature10716 · Cited by 1,383 · cited 2×
“The observed demethylation is spatially limited and, therefore, likely initiated by sequence-dependent transcription factor recruitment, which is in general agreement with recently published comparisons of transcription factor binding and DNA methylation (24,25).”
Aligning Short Sequencing Reads with Bowtie
Langmead, B. (2010) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi1107s32 · Cited by 1,292
Diversity and Complexity in DNA Recognition by Transcription Factors
Badis, G., Berger, M. F., Philippakis, A. A., Talukder, S., Gehrke, A. R., Jaeger, S. A., Chan, E. T., Metzler, G., Vedenko, A., Chen, X., et al. (2009) · Science · doi:10.1126/science.1162327 · Cited by 990 · cited 1×
“1 DNA-binding domain with 8mer sequences on universal protein binding microarrays (28) and observed a good correlation (R(2)=0.”
FoxA1 Translates Epigenetic Signatures into Enhancer-Driven Lineage-Specific Transcription
Lupien, M., Eeckhoute, J., Meyer, C. A., Wang, Q., Zhang, Y., Li, W., Carroll, J. S., Liu, X. S., & Brown, M. (2008) · Cell · doi:10.1016/j.cell.2008.01.018 · Cited by 983
Cited by
The selection and function of cell type-specific enhancers
Heinz, S., Romanoski, C. E., Benner, C., & Glass, C. K. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3949 · Cited by 1,010
Self-citationEffect of natural genetic variation on enhancer selection and function
Heinz, S., Romanoski, C. E., Benner, C., Allison, K. A., Kaikkonen, M. U., Orozco, L. D., & Glass, C. K. (2013) · Nature · doi:10.1038/nature12615 · Cited by 298
Self-citationLanglais, D., Barreiro, L. B., & Gros, P. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151764 · Cited by 256
“1 C), in agreement with recently published data (Pham et al., 2013; Barozzi et al., 2014).”
ResultPU.1 controls fibroblast polarization and tissue fibrosis
Wohlfahrt, T., Rauber, S., Uebe, S., Luber, M., Soare, A., Ekici, A., Weber, S., Matei, A.-E., Chen, C.-W., Maier, C., et al. (2019) · Nature · doi:10.1038/s41586-019-0896-x · Cited by 187
“Like other ETS proteins, PU.1 binds to DNA sites harboring a 5´-GGAA-3´ core consensus sequence 34 .”
Niche signals and transcription factors involved in tissue-resident macrophage development
T'Jonck, W., Guilliams, M., & Bonnardel, J. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.02.005 · Cited by 165
Minderjahn, J., Schmidt, A., Fuchs, A., Schill, R., Raithel, J., Babina, M., Schmidl, C., Gebhard, C., Schmidhofer, S., Mendes, K., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13960-2 · Cited by 136
Self-citationWill, B., Vogler, T. O., Narayanagari, S., Bartholdy, B., Todorova, T. I., da Silva Ferreira, M., Chen, J., Yu, Y., Mayer, J., Barreyro, L., et al. (2015) · Nature Medicine · doi:10.1038/nm.3936 · Cited by 127
de Bruin, R. G., Shiue, L., Prins, J., de Boer, H. C., Singh, A., Fagg, W. S., van Gils, J. M., Duijs, J. M. G. J., Katzman, S., Kraaijeveld, A. O., et al. (2016) · Nature Communications · doi:10.1038/ncomms10846 · Cited by 115
“Recent work by Pham et al. 48 identified that the binding of PU.1 appears to be enhanced by cooperativity with neighbouring transcription factor binding sites, such as KLF4.”
Pharmacological inhibition of the transcription factor PU.1 in leukemia
Antony-Debré, I., Paul, A., Leite, J., Mitchell, K., Kim, H. M., Carvajal, L. A., Todorova, T. I., Huang, K., Kumar, A., Farahat, A. A., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92504 · Cited by 120
“1 is conferred through additional contacts with the minor groove of adjacent AT-rich tracks (24).”
BackgroundHormone-dependent control of developmental timing through regulation of chromatin accessibility
Uyehara, C. M., Nystrom, S. L., Niederhuber, M. J., Leatham-Jensen, M., Ma, Y., Buttitta, L. A., & McKay, D. J. (2017) · Genes & Development · doi:10.1101/gad.298182.117 · Cited by 121
“One proposed mechanism to explain the distinctive power of master transcription factors is that they control where other transcription factors bind in the genome by regulating chromatin accessibility (Fakhouri et al. 2010; Mullen et al. 2011; Pham et al. 2013).”
Mechanisms of Action of Hematopoietic Transcription Factor PU.1 in Initiation of T-Cell Development
Rothenberg, E. V., Hosokawa, H., & Ungerbäck, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00228 · Cited by 99
“, (10, 11)], and it is known to be able to bind either as a pioneer factor which displaces nucleosomes to open sites for other factors (12), or as a collaboration-dependent partner in binding complexes, either with activation-dependent factors like NF-κB or with lineage-defining partners like C/EBPα (or β) or IRF4/8 (…”
BackgroundDubois-Chevalier, J., Oger, F., Dehondt, H., Firmin, F. F., Gheeraert, C., Staels, B., Lefebvre, P., & Eeckhoute, J. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku780 · Cited by 83
“Since these properties have been associated with cell-specific chromatin binding of TFs (60,61), we compared 3T3-L1 conCTS and dynCTS to CTCF cistromes from multiple mouse tissues or celltypes (see ‘Materials and Methods’) obtained from the CTCFBSDB 2.”
MethodUngerbäck, J., Hosokawa, H., Wang, X., Strid, T., Williams, B. A., Sigvardsson, M., & Rothenberg, E. V. (2018) · Genome Research · doi:10.1101/gr.231423.117 · Cited by 77
“1 binding preferences on naked DNA (Supplemental Fig. S1B,C; Pham et al. 2013).”
BackgroundMethodMacrophages: The Potent Immunoregulatory Innate Immune Cells
Kumar, V. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.88013 · Cited by 90
A comprehensive profile of ChIP-Seq-based PU.1/Spi1 target genes in microglia.
Satoh, J.-I., Asahina, N., Kitano, S., & Kino, Y. (2014) · Gene Regulation and Systems Biology · doi:10.4137/grsb.s19711 · Cited by 74
The chromatin landscape and transcription factors in T cell programming
Rothenberg, E. V. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.03.001 · Cited by 89
Epigenetic program and transcription factor circuitry of dendritic cell development
Lin, Q., Chauvistré, H., Costa, I. G., Gusmao, E. G., Mitzka, S., Hänzelmann, S., Baying, B., Klisch, T., Moriggl, R., Hennuy, B., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1056 · Cited by 77
“1 represents a pioneer transcription factor in hematopoietic cell development that acts in concert with other lineage specific factors (25,26,49,67).”
BackgroundConstrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients
Le Coz, C., Nguyen, D. N., Su, C., Nolan, B. E., Albrecht, A. V., Xhani, S., Sun, D., Demaree, B., Pillarisetti, P., Khanna, C., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201750 · Cited by 69
“1 is capable of decompacting dense stem cell heterochromatin to create stably accessible euchromatic regions (Heinz et al., 2010; Pham et al., 2013; Sherwood et al., 2014).”
BackgroundMunde, M., Wang, S., Kumar, A., Stephens, C. E., Farahat, A. A., Boykin, D. W., Wilson, W. D., & Poon, G. M. K. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt955 · Cited by 68
“AT-rich flanking sequences, a feature distinct from other ETS classes (30,43).”
BackgroundEpigenetic Regulation of Kupffer Cell Function in Health and Disease
Bennett, H., Troutman, T. D., Sakai, M., & Glass, C. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.609618 · Cited by 66
Rojo, R., Pridans, C., Langlais, D., & Hume, D. A. (2017) · Clinical Science · doi:10.1042/cs20170238 · Cited by 60
Cirovic, B., Schönheit, J., Kowenz‐Leutz, E., Ivanovska, J., Klement, C., Pronina, N., Bégay, V., & Leutz, A. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.12.015 · Cited by 65
“1 expression that has an impact on lymphomyeloid specification by occupancy of low-affinity binding sites only at high transcription factor concentrations (DeKoter and Singh, 2000; Pham et al., 2013).”
BackgroundEpigenomic PU.1-VDR crosstalk modulates vitamin D signaling
Seuter, S., Neme, A., & Carlberg, C. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2017.02.005 · Cited by 57
Wang, S., Poon, G. M. K., & Wilson, W. D. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2877-4_20 · Cited by 52
“Factor-specific interactions with their target DNA represent major specificity determinants, as evidenced by the strong correspondence of sequence preference of ETS domains in vitro to genomic occupancy of native ETS proteins in vivo (21, 26).”
BackgroundEpigenetic control of hematopoiesis: the PU.1 chromatin connection
van Riel, B., & Rosenbauer, F. (2014) · Biological Chemistry · doi:10.1515/hsz-2014-0195 · Cited by 48
NextPBM: a platform to study cell-specific transcription factor binding and cooperativity
Mohaghegh, N., Bray, D., Keenan, J. L., Penvose, A. R., Andrilenas, K. K., Ramlall, V., & Siggers, T. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz020 · Cited by 66
“1 binding to unmarked loci is in agreement with previous studies (43) and suggests that PU.”
ResultPharmacologic efficacy of PU.1 inhibition by heterocyclic dications: a mechanistic analysis
Stephens, D. C., Kim, H. M., Kumar, A., Farahat, A. A., Boykin, D. W., & Poon, G. M. K. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw229 · Cited by 38
“1-binding sites varies (21,22), and to establish FP measurements of DB270/DNA binding, we titrated DB270 with duplex DNA oligos harboring B or two other PU.”
MethodKarpurapu, M., Ranjan, R., Deng, J., Chung, S., Lee, Y. G., Xiao, L., Nirujogi, T. S., Jacobson, J. R., Park, G. Y., & Christman, J. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093362 · Cited by 41
“1 motif binding affinity and co-operative interaction with neighboring transcription factors [38].”
BackgroundStephens, D. C., & Poon, G. M. K. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw528 · Cited by 37
“1, but not Ets-1, as a pioneer transcription factor that capable of occupying methylated cognate DNA sites in vivo (48).”
BackgroundHematopoiesis and T‐cell specification as a model developmental system
Rothenberg, E. V., Kueh, H. Y., Yui, M. A., & Zhang, J. A. (2016) · Immunological Reviews · doi:10.1111/imr.12417 · Cited by 36
Ha, S.-D., Cho, W., DeKoter, R. P., & Kim, S. O. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010149 · Cited by 36
“1-binding sites (GGAAGTG (45); 513, 2,285, 9,476, 9,870, and 10,124 bases upstream of the TSS) were found (Fig.”
Runx factors launch T cell and innate lymphoid programs via direct and gene network-based mechanisms
Shin, B., Zhou, W., Wang, J., Gao, F., & Rothenberg, E. V. (2023) · Nature Immunology · doi:10.1038/s41590-023-01585-z · Cited by 34
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting Therapies
Su, A. H., Ling, F. W., Vaganay, C., Sodaro, G., Benaksas, C., Bello, R. D., Forget, A., Pardieu, B., Lin, K., Rutter, J. C., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0970 · Cited by 38
“These programs are tightly linked through physical interactions between SPI1 and IRF4 or IRF8 in hematopoietic stem and progenitor cells (34, 35).”
BackgroundTranscriptional Regulation and Macrophage Differentiation
Hume, D. A., SUMMERS, K. M., & Rehli, M. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0024-2015 · Cited by 37
Self-citationTan, C., & Takada, S. (2018) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.8b00299 · Cited by 33
Pioneer factors in development and cancer
Sunkel, B. D., & Stanton, B. Z. (2021) · iScience · doi:10.1016/j.isci.2021.103132 · Cited by 33
“PU.1 motifs can be occupied in gene deserts or inaccessible regions in macrophages, which is consistent with pioneer function (Pham et al., 2013).”
BackgroundTranscriptional network dynamics in early T cell development
Shin, B., Chang, S. J., MacNabb, B. W., & Rothenberg, E. V. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20230893 · Cited by 30
“Binding of the pioneer factor PU.1 (Frederick et al., 2023; Minderjahn et al., 2020; Pham et al., 2013) prominently contributes to the chromatin accessibility landscape in these cells (Ungerb¨ack et al., 2018).”
Wang, S., Linde, M. H., Munde, M. M., Carvalho, V. D., Wilson, W. D., & Poon, G. M. K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.575340 · Cited by 39
Structural mechanism of synergistic targeting of the CX3CR1 nucleosome by PU.1 and C/EBPα
Lian, T., Guan, R., Zhou, B., & Bai, Y. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01189-z · Cited by 28
“PU.1 binds to its DNA motif alone or co-binds with other factors, such as the C/EBPα family nearby at the enhancers of cell type-specific genes, and regulates their expression 20,21 .”
Gregoricchio, S., Polit, L., Esposito, M., Berthelet, J., Delestré, L., Evanno, E., Diop, M., Gallais, I., Aleth, H., Poplineau, M., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac613 · Cited by 27
“In myeloid and B-lymphoid cells, SPI1 activates lineage-specific genes due to lineage-specific coactivators at enhancers (6,7,68).”
BackgroundEpigenetic Regulation of Myeloid Cells
Ivashkiv, L. B., & Park, S. H. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0010-2015 · Cited by 29
Signatures of DNA target selectivity by ETS transcription factors
Poon, G. M. K., & Kim, H. M. (2017) · Transcription · doi:10.1080/21541264.2017.1302901 · Cited by 30
“1 to autonomously engage methylated DNA in vivo.(48)”
BackgroundHume, D. A., Wollscheid-Lengeling, E., Rojo, R., & Pridans, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-15999-x · Cited by 27
Martin-Estebane, M., & Gomez-Nicola, D. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00149 · Cited by 25
“1-box) located upstream of the promoter of its targets and activates the expression of a great number of downstream genes (Pham et al., 2013).”
BackgroundNoncoding RNAs and LRRFIP1 Regulate TNF Expression
Shi, L., Li, S., Fitzgerald, M., Maurer, K., Bagashev, A., & Sullivan, K. E. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302063 · Cited by 28
DiSpirito, J. R., Fang, B., Wang, F., & Lazar, M. A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00599-13 · Cited by 29
“1 and C/EBP can function as “pioneering” transcription factors that bind to inaccessible regions of DNA and facilitate their remodeling (41, 46).”
BackgroundDNA selection by the master transcription factor PU.1
Terrell, J. R., Taylor, S. J., Schneider, A. L., Lu, Y., Vernon, T. N., Xhani, S., Gumpper, R. H., Luo, M., Wilson, W. D., Steidl, U. G., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112671 · Cited by 25
Czimmerer, Z., Nagy, Z. S., Nagy, G., Horváth, A., Cseh, T., Kriston, A., Jonas, D., Sauer, S., Steiner, L., Dániel, B., et al. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.07.034 · Cited by 29
Taylor, S. J., Stauber, J., Bohorquez, O., Tatsumi, G., Kumari, R., Chakraborty, J., Bartholdy, B. A., Schwenger, E., Sundaravel, S., Farahat, A. A., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01911-7 · Cited by 22
“CUT&Tag identified 34,904 total PU.1 binding sites, consistent with the number of PU.1 peaks found in prior localization studies 28–30 , with 19% of sites being lost and 15% being gained following DB2115 exposure ( n = 3, Diffbind false discovery rate (FDR) < 0.1; Fig.”
InfluentialLogic and lineage impacts on functional transcription factor deployment for T-cell fate commitment
Rothenberg, E. V. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.04.002 · Cited by 17
Guo, P., Farahat, A. A., Paul, A., Boykin, D. W., & Wilson, W. D. (2021) · Chemical Science · doi:10.1039/d1sc04720e · Cited by 16
Organizing combinatorial transcription factor recruitment atcis-regulatory modules
Dubois‐Chevalier, J., Mazrooei, P., Lupien, M., Staels, B., Lefèbvre, P., & Eeckhoute, J. (2017) · Transcription · doi:10.1080/21541264.2017.1394424 · Cited by 18
“Indirect functional interference between TFs often involves modulation of their binding to CRMs through chromatin-based mechanisms [8,9].”
BackgroundHIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages
Virgilio, M. C., Ramnani, B., Chen, T., Disbennett, W. M., Lubow, J., Welch, J. D., & Collins, K. L. (2024) · Nature Communications · doi:10.1038/s41467-024-49635-w · Cited by 14
“27,42,43).”
Rhee, C., Scadden, E. W., Wong, L. P., Schiroli, G., Mazzola, M. C., Chea, P. L., Kato, H., Hoyer, F. F., Mistry, M., Lee, B., et al. (2023) · Blood · doi:10.1182/blood.2023020257 · Cited by 14
Studying epigenetic interactions using MicroScale Thermophoresis (MST)
Schubert, T. E. O., & Längst, G. (2015) · AIMS Biophysics · doi:10.3934/biophy.2015.3.370 · Cited by 14
“Besides others [14–18], the study of Pham and colleagues [19] on the hematopoietic master”
BackgroundInfluentialSelf-citationHe, G., Tolic, A., Bashkin, J. K., & Poon, G. M. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv267 · Cited by 18
Nagy, D., Maude, H., Birdsey, G. M., RANDI, A. M., & Cebola, I. (2023) · Journal of Molecular Endocrinology · doi:10.1530/jme-23-0026 · Cited by 13
Rothenberg, E. V., Champhekar, A. S., Damle, S. S., Real, M. M. D., Kueh, H. Y., Li, L., & Yui, M. A. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020271 · Cited by 17
“It has well-documented genomewide profiles of target gene binding in different non-T contexts (Ghisletti et al. 2010; Heinz et al. 2010; Pham et al. 2013).”
BackgroundTranscription factors that define the epigenome structures and transcriptomes in microglia
Saeki, K., & Ozato, K. (2025) · Experimental Hematology · doi:10.1016/j.exphem.2025.104814 · Cited by 11
The roles of ETS transcription factors in liver fibrosis
Zhang, L.-Y., Tan, Y., Luo, X., Wu, J., & Ni, Y. (2022) · Human Cell · doi:10.1007/s13577-022-00848-5 · Cited by 12
Pioneer factors in viral infection
Neugebauer, E., Bastidas-Quintero, A. M., Weidl, D., & Full, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1286617 · Cited by 10
Nouri, M., Deezagi, A., & Ebrahimi, M. (2016) · Annals of Hematology · doi:10.1007/s00277-015-2583-9 · Cited by 10
“1 concentration on hematopoietic cell fate decision has also been mentioned in different studies [24, 25].”
Jeong, R., & Bulyk, M. L. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100327 · Cited by 11
Epigenetic aspects of DC development and differentiation
Chauvistré, H., & Seré, K. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.10.011 · Cited by 10
Reconstructing the regulatory programs underlying the phenotypic plasticity of neural cancers
Larsson, I., Held, F., Popova, G., Koc, A., Kundu, S., Jörnsten, R. J., & Nelander, S. (2024) · Nature Communications · doi:10.1038/s41467-024-53954-3 · Cited by 12
Weilert, M., Brennan, K., Dalal, K., Krueger, S., Jiang, H., Martinez-Corral, R., & Zeitlinger, J. (2026) · Cell Genomics · doi:10.1016/j.xgen.2026.101339 · Cited by 8
“Since low-affinity motifs are bound at higher TF concentrations, 10 they allow developmental enhancers to respond at higher TF concentration ranges during embryonic development, 9,26–30 making them susceptible to TF dosage-dependent phenotypic changes.”
Comparative analysis of neutrophil and monocyte epigenomesPreprint
Rico, D., Martens, J. H. A., Downes, K., Pau, E. C. D. S., Pancaldi, V., Breschi, A., Richardson, D., Heath, S. C., Saeed, S., Frontini, M., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/237784 · Cited by 6
Cellular imbalance in proximal and distal lung of CFTR−/− sheep in utero and at birth
Leir, S., Tkachenko, S., Paranjapye, A., Wettere, A. J. V., Kerschner, J. L., Périssé, I. V., Marriott, C. M., Patrick, T., Liu, Y., White, K. L., et al. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01266-7 · Cited by 5
Wang, C., Wang, Y., Gu, Y., Zhu, Y., Yin, R., Yang, L., & Gui, J. (2025) · Journal of Tissue Engineering · doi:10.1177/20417314241311073 · Cited by 6
The Cardiac Stress Response Factor Ms1 Can Bind to DNA and Has a Function in the Nucleus
Zaleska, M., Fogl, C., Kho, A. L., Ababou, A., Ehler, E., & Pfuhl, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144614 · Cited by 7
“While numerous transcription factors bind to their recognition sites with nanomolar affinities [45,46] others do bind with affinities comparable to that of ABD2, e.”
Transcriptional Regulation and Macrophage Differentiation
Hume, D. A., SUMMERS, K. M., & Rehli, M. (2017) · ASM Press eBooks · doi:10.1128/9781555819194.ch8 · Cited by 5
Self-citationMARADONER: Motif Activity Response Analysis Done Right
Meshcheryakov, G. A., Buyan, A., Favorov, A. V., Makeev, V. J., & Kulakovskiy, I. V. (2026) · International Conference on Bioinformatics and Biomedical Technology (ICBBT) · doi:10.1145/3822521.3822537 · Cited by 4
Mišković, R., Ljubičić, J., Nikolic, B. B., Petković, A., Marković, V., Ranković, I., Djordjevic, J., Stankovic, A., Klaassen, K., Pavlović, S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1324679 · Cited by 6
“The primary function of PU.1 is decompacting heterochromatin and enabling other TFs important for hematopoietic cell development to approach previously unreachable sequences (10).”
BackgroundYang, Q., Liu, J., Zhang, T., Zhu, T., Yao, S., Wang, R., Wang, W., Dilimulati, H., Ge, J., & An, S. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1477903 · Cited by 4
Wang, M., Zhang, M., Qiu, J., Liu, C., Lou, Y., Wang, T., Zhang, Y., & Mao, Y. (2023) · BMC Immunology · doi:10.1186/s12865-023-00539-2 · Cited by 4
“1 activates downstream targets by binding to typical (A/G)AGG AAG TG motifs [12, 14, 15].”
BackgroundSingle-nucleus multiple-organ chromatin accessibility landscape in the adult rat
Li, R., Yuan, Y., Duan, S., Deng, Q., Ma, W., Liu, C., Gao, P., Lu, L., & Liu, C. (2026) · GigaScience · doi:10.1093/gigascience/giag013 · Cited by 3
“For example, Sfpi1 [ 26 , 27 ], a TF linked to the formation of blood cells, is specifically enriched in immune cells (especially Kupffer cells, ovarian macrophages, and splenic macrophages), indicating that it plays a pivotal role in immune cell differ entiation and function.”
Burger, L., Gil, N., & Schübeler, D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.11.669605 · Cited by 3
Notch interaction with RUNX factors regulates initiation of the T-lineage program
Kama, Y., Hirano, K.-I., Masuhara, K., Endo, Y., Suzuki, Y., Fujimoto, M., Matsuda, T., Yahata, T., Kato, M., Hozumi, K., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20250911 · Cited by 3
“…enriched near genomic regions occupied by key lineage-specifying TFs in multiple hematopoietic lineages (Hosokawa et al., 2021a; Hosokawa et al., 2020; Hosokawa et al., 2018a; Hosokawa et al., 2018b; Miyazaki et al., 2017; Pham et al., 2013; Ungerb¨ack et al., 2018; Van de Walle et al., 2016).”
Lim, C. S., Gu, J. K., & Ma, Q. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03925-w · Cited by 2
“…sequence resembles the binding sequence (xxAGGAAxx) for the transcription factor PU.1, an E26 transformation-specific (ETS)-domain-containing transcription factor required for myeloid and B-lymphoid cell development (Klemsz et al. 1990; McKercher et al. 1996; Pham et al. 2013; Scott et al. 1994).”
Daddali, R., Kettunen, K., Turunen, T., Knox, A. V. C., Laine, P., Chowdhury, I. M., Vänttinen, M., Mamia, N., Stiegler, A. L., Boggon, T. J., et al. (2025) · Clinical Immunology · doi:10.1016/j.clim.2025.110503 · Cited by 3
Pioneering, chromatin remodeling, and epigenetic constraint in early T-cell gene regulation by PU.1Preprint
Ungerbäck, J., Hosokawa, H., Wang, X., Strid, T., Williams, B. A., Sigvardsson, M., & Rothenberg, E. V. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/331710 · Cited by 2
Myelopoiesis specific gene expression profiling in human CD34+ hematopoietic stem cells
Joshi, M., & Gangenahalli, G. U. (2020) · Gene Expression Patterns · doi:10.1016/j.gep.2020.119128 · Cited by 1
Single-cell analysis of gene regulatory networks in the mammary glands of P4HA1-knockout mice
Gupta, A., Huang, L., Liu, J., Chen, K., Xu, R., & Wu, W. (2025) · PLoS Genetics · doi:10.1371/journal.pgen.1011505 · Cited by 1
Distinct gene regulatory networks govern hematopoietic and leukemia stem cellsPreprint
Zhang, B., Murison, A. J., Varesi, A., Takayama, N., Jin, L., Mbong, N., Schoof, E. M., Xie, S. Z.-J., Mitchell, A., Etchin, J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.28.614980 · Cited by 1
“As shown by others, higher motif scores frequently indicate more likely TF binding events, as confirmed using ChIP-Seq assays 34,35 .”
BackgroundBarozzi, I. (2014) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/barozzi-iros-giacomo_phd2014-03-25
“A recent paper (Pham et al., 2013) shed some light into the mechanisms of Pu.”
BackgroundInfluentialNieto, V. (2019) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.40236
Mesothelium-derived factors shape tissue resident macrophage
Lai, C. (2019) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/regx-j539
Epigenetic Regulation of Myeloid Cells
Ivashkiv, L. B., & Park, S. H. (2017) · ASM Press eBooks · doi:10.1128/9781555819194.ch31
Faculty Opinions recommendation of PU.1 controls fibroblast polarization and tissue fibrosis.
Nanchahal, J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734947940.793569335
Tiwari, V. K., & Mariappan, A. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737244626.793573181
Jones, R. E., Hill, M., & Taylor, P. (2022) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17705.1
Reconstructing the regulatory programs underlying the phenotypic plasticity of neural cancersPreprint
Larsson, I., Held, F., Popova, G., Koc, A., Jörnsten, R. J., & Nelander, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.10.532041 · Cited by 1
Su, A. H., Ling, F., Vaganay, C., Sodaro, G., Benaksas, C., Bello, R. D., Forget, A., Pardieu, B., Lin, K., Rutter, J. C., et al. (2023) · doi:10.1158/2159-8290.22535072
Reconstructing the regulatory programs underlying the phenotypic plasticity of neural cancersPreprint
Nelander, S., Larsson, I., Held, F., Popova, G., Koc, A., Kundu, S., & Jörnsten, R. J. (2024) · Research Square · doi:10.21203/rs.3.rs-3658321/v1
Rôle du système XCT dans l'oncogènese des leucemies augües myeloïdes
Pardieu, B. (2021) · theses.fr (ABES) · doi:10.70675/a354501fz18e2z45e6zbfc6z9f8a2c599d94
Gregoricchio, S. (2021) · theses.fr (ABES) · doi:10.70675/f1d71abdzfa19z4e95z89e6zdfa431de5448
Wang, M., Zhang, M., Qiu, J., Liu, C., Lou, Y., Wang, T., Zhang, Y., & Mao, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22601137
Wang, M., Zhang, M., Qiu, J., Liu, C., Lou, Y., Wang, T., Zhang, Y., & Mao, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22601134
Metadata
- Authors
- Pham, T.-H., Minderjahn, J., Schmidl, C., Hoffmeister, H., Schmidhofer, S., Chen, W., Längst, G., Benner, C., & Rehli, M.
- Affiliations
- University Hospital Regensburg (DE)
- Salk Institute for Biological Studies (US)
- Corresponding author
- Rehli, Michael
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-05-08
- Volume
- 41
- Issue
- 13
- Pages
- 6391-6402
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC3711439
- OpenAlex
- W2131580913
- Cited by
- 102
- References
- 42
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 12 · 2023: 11 · 2022: 3 · 2021: 6 · 2020: 7 · 2019: 7 · 2018: 4 · 2017: 12 · 2016: 8 · 2015: 7 · 2014: 8 · 2013: 4
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Nucleic Acids Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- University of Regensburg Publication Server (University of Regensburg) (acceptedVersion)
- University of Regensburg Publication Server (University of Regensburg)
- Funders
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Universität Regensburg
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- PU.1, macrophage differentiation, hematopoietic differentiation, chromatin domains, DNA methylation, cell type-specific gene regulation, transcription factor concentration
- MeSH terms
- Proto-Oncogene Protein Spi-1, Base Sequence, Binding Sites, Chromatin, Deoxyribonuclease I, DNA, Humans, Macrophages, Monocytes, Protein Binding, Proto-Oncogene Proteins, Stem Cells, Trans-Activators, Consensus Sequence, Nucleotide Motifs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.